Investor Relations

Press Releases

Date Title and Summary View
Toggle Summary NanoString Announces Preliminary Revenue for Third Quarter of Fiscal Year 2017
SEATTLE , Oct. 11, 2017 (GLOBE NEWSWIRE) -- NanoString Technologies, Inc. (NASDAQ:NSTG), a provider of life science tools for translational research and molecular diagnostic products, today announced preliminary total revenue of approximately $25.9 million to $26.9 million for the third quarter,
View HTML
Toggle Summary NanoString's Hyb & Seq™ Enables Liquid Biopsy by the Direct Capture and Sequencing of Cell-Free DNA
Simple Workflow Allows Target Capture and Sequencing Initiation in About One Hour
View HTML
Toggle Summary NanoString to Webcast Presentation at the 2017 Morgan Stanley Global Healthcare Conference
SEATTLE , Sept. 07, 2017 (GLOBE NEWSWIRE) -- NanoString Technologies , Inc. (NASDAQ:NSTG), a provider of life science tools for translational research and molecular diagnostic products, today announced that it will webcast the company's presentation at the 2017 Morgan Stanley Global Healthcare
View HTML
Toggle Summary Anthem Issues Positive Coverage Decision for NanoString's Prosigna® Breast Cancer Assay
SEATTLE , Sept. 05, 2017 (GLOBE NEWSWIRE) -- NanoString Technologies, Inc. (NASDAQ:NSTG), a provider of life science tools for translational research and molecular diagnostic products, today announced that Anthem has issued a positive coverage decision for the Prosigna® Breast Cancer Gene Signature
View HTML
Toggle Summary NanoString to Webcast Presentation at the 2017 Baird Global Healthcare Conference
SEATTLE , Aug. 31, 2017 (GLOBE NEWSWIRE) -- NanoString Technologies , Inc. (NASDAQ:NSTG), a provider of life science tools for translational research and molecular diagnostic products, today announced that it will webcast the company's presentation at the 2017 Baird Global Healthcare Conference in
View HTML
Toggle Summary NanoString Technologies Releases Operating Results for Second Quarter of 2017
SEATTLE , Aug. 08, 2017 (GLOBE NEWSWIRE) -- NanoString Technologies, Inc. (NASDAQ:NSTG), a provider of life science tools for translational research and molecular diagnostic products, today reported financial results for the second quarter of 2017.  Second Quarter Financial Highlights   Total
View HTML
Toggle Summary NanoString and Lam Research Announce Strategic Development Collaboration to Advance Hyb & Seq Next Generation Sequencing Platform
Partnership Brings Together Leaders in Nanoscale Technology and Molecular Profiling
View HTML
Toggle Summary NanoString to Release Second Quarter 2017 Financial Results and Host Conference Call on Tuesday, August 8, 2017
SEATTLE , July 10, 2017 (GLOBE NEWSWIRE) -- NanoString Technologies, Inc. (NASDAQ:NSTG), a provider of life science tools for translational research and molecular diagnostic products, today announced that the Company will release second quarter 2017 financial results after the close of trading on
View HTML
Toggle Summary NanoString Appoints J. Chad Brown as Senior Vice President of Sales and Marketing
SEATTLE , July 05, 2017 (GLOBE NEWSWIRE) -- NanoString Technologies, Inc. (NASDAQ:NSTG), a provider of life science tools for translational research and molecular diagnostic products, today announced that J. Chad Brown has been appointed Senior Vice President of Sales and Marketing, effective July
View HTML
Toggle Summary NanoString Technologies Announces Closing of Public Offering of 3,450,000 Shares of Common Stock Including Exercise in Full of Option to Purchase Additional Shares
SEATTLE , June 06, 2017 (GLOBE NEWSWIRE) -- NanoString Technologies, Inc. (NASDAQ:NSTG), a provider of life science tools for translational research and molecular diagnostic products, today announced the closing of its previously announced underwritten public offering of 3,450,000 shares of its
View HTML